| Literature DB >> 8283190 |
Abstract
I argue in this paper that the use of a global clinical impression of change as a primary measure in dementia drug trials is appropriate, given that we do not yet understand clearly enough what Alzheimer's disease looks like as it gets better.Entities:
Mesh：
Year: 1994 PMID： 8283190 DOI： 10.1016/0895-4356(94)90039-6
Source DB: PubMed Journal: J Clin Epidemiol ISSN： 0895-4356 Impact factor: 6.437